DrugPatentWatch Database Preview

Litigation Details for Cornerstone Biopharma Inc. v. Exela Pharma Sciences LLC (D. Del. 2013)

« Back to Dashboard

Cornerstone Biopharma Inc. v. Exela Pharma Sciences LLC (D. Del. 2013)

Docket		Date Filed	2013-07-24
Court	District Court, D. Delaware	Date Terminated	2015-12-14
Cause	35:145 Patent Infringement	Assigned To	Gregory Moneta Sleet
Jury Demand	None	Referred To
Patents	6,660,715; 7,612,102; 7,659,291; 8,048,017; 8,449,909; 8,455,524; 8,557,291; 9,022,022
Link to Docket	External link to docket

Details for Cornerstone Biopharma Inc. v. Exela Pharma Sciences LLC (D. Del. 2013)

Date Filed	Document No.	Description	Snippet	Link To Document
2013-07-24	1		Code, involving United States Patent No. 7,612,102 (“the ’102 patent”) (attached as Exhibit A hereto… § 355(b)(1), the ’102 patent and the ’291 patent (collectively, “the Patents-in-Suit”) are listed in…. This is an action for patent infringement arising under the patent laws of the United States, …hereto), and United States Patent No. 7,659,291 (“the ’291 patent”) (attached as Exhibit B hereto). …certification”) with regard to the ’102 patent and the ’291 patent (“Exela’s Notice Letter”).	External link to document
2015-07-09	105		U.S. Patent Nos. 7,612,102("the'102 patent"); 7,659,290 ("the '290 patent"… ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,612,102; 7,659,290; 7,659,291 and 8,455,524. Signed…CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,612,102; 7,659,290; 7,659,291and8,455,524 …7,659,291 ("the '291 patent"); and 8,455,524 ("the '524 patent") (collectively, the… the "patents-in-suit"): 1. The term "a pre-mixed aqueous solution&	External link to document
2013-08-19	20		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,612,102 B2; US 7,659,291 … 14 December 2015 1:13-cv-01275-GMS Patent None District Court, D. Delaware	External link to document
2013-07-24	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,612,102 B2; US 7,659,291 … 14 December 2015 1:13-cv-01275-GMS Patent None District Court, D. Delaware	External link to document
2015-02-20	53		macromolecules for pulmonary delivery. U.S. Patent No. 6,660,715; December 9, 2003. 16. Tiller, J.C.,…infringement of U.S. Patent Nos. 7,612,102 (“the ’102 patent”), 7,695,290 (“the ’290 patent”), 7,659,291 (… (“the ’291 patent”), and 8,455,524 (“the ’524 patent”) (collectively, “the patents in suit”), all of…inventor of 18 issued United States patents and of a number of foreign patents. I have given 370 invited lectures… ’291 patent, claims 1–3, 8 ’524 patent, claims 1–3, 8, 19–22	External link to document
2015-02-20	56		U.S. Patent Nos. 7,612,102 (“the ’102 Patent”), 7,659,290 (“the ’290 Patent”), 7,659,291 (“the ’291 Patent…The ’290 and ’291 Patents are divisional patents of the ’102 Patent, and the ’524 Patent is a continuation… Patent”) and 8,455,524 (“the ’524 Patent”). The patents in suit are all from the same family,2 and they… the ’102 Patent is the parent or grandparent to the other patents in suit, and the patents have the …INTRODUCTION This patent infringement action involves four patents relating to the drug product	External link to document
2015-02-27	57		four patents- in-suit, U.S. Patent Nos. 7,612,102 (“the ’102 patent”), 7,659,290 (“the ’290 patent”), …7,659,291 (“the ’291 patent”), and 8,455,524 (“the ’524 patent”) (collectively, the “patents-in-suit”).1 … to the specifications of the patents-in-suit are to the ’102 patent. 4 Concentrated, injectable nicardipine…5 The patents-in-suit are all children of the application that issued as the ’102 patent. “[P]…“prior art cited in a patent or cited in the prosecution history of the patent constitutes intrinsic	External link to document